NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 292 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $785,697 | -34.4% | 48,650 | -68.7% | 0.01% | -33.3% |
| Q4 2022 | $1,198,336 | +28.0% | 155,342 | +1274.7% | 0.01% | +12.5% |
| Q1 2022 | $936,000 | +343.6% | 11,300 | +523.6% | 0.01% | +300.0% |
| Q3 2021 | $211,000 | -64.2% | 1,812 | -65.8% | 0.00% | -81.8% |
| Q3 2020 | $589,000 | -40.4% | 5,296 | -63.9% | 0.01% | -82.3% |
| Q1 2020 | $988,000 | -12.5% | 14,674 | -2.8% | 0.06% | +87.9% |
| Q3 2019 | $1,129,000 | – | 15,097 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |